Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DABI-ADP-1
2011-000503-40Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dabigatran in Atrial fibrillation (AFib) (2 arms), sponsored by Deutsches Herzzentrum München. Primary endpoint: Peak maximal ADP-induced platelet aggregation at day 14. Started Feb 2011; status: completed.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2011-000503-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000503-40.